DEA Cannabis Rescheduling Hearing Faces Public Access Pressure

Legal advocates and industry stakeholders are mounting pressure on DEA administrative law judge John Mulrooney to allow public livestream access to upcoming cannabis rescheduling hearings. The push for transparency comes as the agency prepares for what could become the most consequential federal cannabis policy proceedings in decades, with direct implications for the $30 billion legal cannabis market.

The DEA's administrative hearing process represents a critical juncture in the federal rescheduling timeline that began with the Biden administration's directive to review cannabis classification. Multiple legal organizations argue that public access to these proceedings is essential given the widespread economic and social implications of potential Schedule III reclassification, which would fundamentally alter the regulatory landscape for cannabis operators nationwide.

Public access to the hearings would provide unprecedented transparency into federal decision-making processes that directly impact cannabis valuations across all market segments. The rescheduling decision affects everything from banking access and interstate commerce to the Section 280E tax burden that currently hampers profitability for licensed operators. Cannabis companies have collectively paid billions in additional federal taxes due to current Schedule I restrictions.

The timing of these proceedings coincides with increasing institutional investor interest in cannabis assets, as major financial firms position for potential federal policy shifts. Livestream access would allow market participants to assess regulatory momentum in real-time, potentially reducing volatility driven by speculation and incomplete information about the rescheduling process.

While the DEA maintains discretion over hearing procedures, the agency faces mounting scrutiny over transparency in cannabis policy development. The administrative law judge's decision on public access could signal broader federal attitudes toward cannabis industry legitimacy and stakeholder engagement in regulatory processes that shape market fundamentals.